Basic information
- Name:
4H-Pyrano[2,3-b][1,4]benzodioxin-4-one,decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-,(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-
- Superlist Name:
- Spectinomycin
- CAS No.:
1695-77-8
- Molecular Structure:
![Molecular Structure of 1695-77-8 (4H-Pyrano[2,3-b][1,4]benzodioxin-4-one,decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-,(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-)](http://www.lookchem.com/300w/2010/0619/1695-77-8.jpg)
- Formula:
- C14H24N2O7
- Molecular Weight:
- 332.35
- Synonyms:
- 4H-Pyrano[2,3-b][1,4]benzodioxin-4-one,decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)- (7CI,8CI);4H-Pyrano[2,3-b][1,4]benzodioxin-4-one,decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, [2R-(2a,4ab,5ab,6b,7b,8b,9a,9aa,10ab)]-;Actinospectacin;Antibiotic 2233wp;Espectinomicina;M 141;Spectacin;Spectam;Togamycin;Trobicin;U 18409E;
- EINECS:
- 216-911-3
- Density:
- 1.43 g/cm3
- Boiling Point:
- 583.1 °C at 760 mmHg
- Flash Point:
- 306.4 °C
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Chemistry
Empirical Formula: C14H24N2O7
Molecular Weight: 332.3496g/mol
EINECS: 216-911-3
Structure of 4H-Pyrano[2,3-b][1,4]benzodioxin-4-one,decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-,(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)- (CAS NO.1695-77-8):
Index of Refraction: 1.586
Molar Refractivity: 77.81 cm3
Molar Volume: 231.6 cm3
Polarizability: 30.84×10-24cm3
Surface Tension: 64.2 dyne/cm
Density: 1.43 g/cm3
Flash Point: 306.4 °C
Enthalpy of Vaporization: 100.06 kJ/mol
Boiling Point: 583.1 °C at 760 mmHg
Vapour Pressure: 5.05E-16 mmHg at 25°C
Classification Code: Anti-Bacterial Agents, Anti-Infective Agents, Drug / Therapeutic Agent, Natural Product
Canonical SMILES: CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O
Isomeric SMILES: C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O
InChI: InChI=1S/C14H24N2O7/c1-5-4-6(17)14(20)13(21-5)22-12-10(19)7(15-2)9(18)8(16-3)11(12)23-14/h5,7-13,15-16,18-20H,4H2,1-3H3/t5-,7-,8+,9+,10+,11-,12-,13+,14+/m1/s1
InChIKey: UNFWWIHTNXNPBV-WXKVUWSESA-N
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LD | intravenous | > 800mg/kg (800mg/kg) | BEHAVIORAL: ATAXIA | Antimicrobial Agents and Chemotherapy Vol. -, Pg. 507, 1961. |
| dog | LD | oral | > 1gm/kg (1000mg/kg) | Antimicrobial Agents and Chemotherapy Vol. -, Pg. 507, 1961. | |
| monkey | LD | oral | > 500mg/kg (500mg/kg) | Antimicrobial Agents and Chemotherapy Vol. -, Pg. 507, 1961. | |
| mouse | LD | intravenous | > 2gm/kg (2000mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS GASTROINTESTINAL: NAUSEA OR VOMITING BEHAVIORAL: ATAXIA | Antimicrobial Agents and Chemotherapy Vol. -, Pg. 507, 1961. |
| mouse | LD50 | intravenous | 2gm/kg (2000mg/kg) | "Index of Antibiotics from Actinomycetes," Umezawa, H. et al., eds., Tokyo, Univ. of Tokyo Press, 1967Vol. -, Pg. 105, 1967. | |
| mouse | LDLo | oral | 20gm/kg (20000mg/kg) | Antimicrobial Agents and Chemotherapy Vol. -, Pg. 507, 1961. | |
| rabbit | LD | unreported | > 40mg/kg (40mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Antimicrobial Agents and Chemotherapy Vol. -, Pg. 507, 1961. |
| rat | LD50 | intraperitoneal | 5724mg/kg (5724mg/kg) | Bollettino Chimico Farmaceutico. Vol. 111, Pg. 265, 1972. | |
| rat | LD50 | oral | > 5gm/kg (5000mg/kg) | Bollettino Chimico Farmaceutico. Vol. 111, Pg. 265, 1972. |
Specification
4H-Pyrano[2,3-b][1,4]benzodioxin-4-one,decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-,(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)- , its cas register number is 1695-77-8. It also can be called Actinospectacin ;
Actinospectacina ; Antibiotic 2233wp ; BRN 2171701 ; Espectinomicina ; M-141 ; Spectam ; Spectinomicina ;
Spectinomycin ; Spectinomycine ; Spectinomycinum ; Togamycin ; Trobicin ; U 18409 E ; UNII-93AKI1U6QF .
